Genmab A (GMAB) Current Taxes (2023 - 2025)
Historic Current Taxes for Genmab A (GMAB) over the last 3 years, with Q4 2025 value amounting to $43.0 million.
- Genmab A's Current Taxes fell 8200.84% to $43.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $43.0 million, marking a year-over-year decrease of 8200.84%. This contributed to the annual value of $43.0 million for FY2025, which is 8200.84% down from last year.
- Genmab A's Current Taxes amounted to $43.0 million in Q4 2025, which was down 8200.84% from $120.0 million recorded in Q3 2025.
- In the past 5 years, Genmab A's Current Taxes ranged from a high of $239.0 million in Q4 2024 and a low of -$228.0 million during Q3 2024
- For the 3-year period, Genmab A's Current Taxes averaged around -$5.0 million, with its median value being $8.0 million (2023).
- In the last 5 years, Genmab A's Current Taxes soared by 288750.0% in 2024 and then plummeted by 8200.84% in 2025.
- Quarter analysis of 3 years shows Genmab A's Current Taxes stood at $8.0 million in 2023, then soared by 2887.5% to $239.0 million in 2024, then tumbled by 82.01% to $43.0 million in 2025.
- Its Current Taxes was $43.0 million in Q4 2025, compared to $120.0 million in Q3 2025 and $40.0 million in Q2 2025.